Extracellular Vesicles of Pseudomonas: Friends and Foes
Tania Henriquez1, Chiara Falciani1
1Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Abstract:
Extracellular vesicles (Evs) are small spherical vesicles capable of transporting molecules (such as proteins, nucleic acids and lipids) from one cell to another. They have been implicated in processes such as cell-to-cell communication, pathogenicity, biofilm formation and metabolism. In parallel, Evs have been proposed as interesting biotechnological tools. In recent years, antibiotic resistance has become a major problem for human health worldwide. A pathogen singled out as among the most lethal antibiotic-resistant organisms is Pseudomonas aeruginosa, an important Gram-negative bacterium that has been extensively studied for the production and characterization of Evs. Here, we describe the advances made in the last decade regarding understanding of the role of Evs in the pathogenicity of Pseudomonas. We also examine the potential of Evs for the development of new treatment strategies.
Insights
Extracellular vesicles (Evs) from Pseudomonas aeruginosa play a key role in its pathogenicity. Understanding these Evs offers potential for developing new strategies to combat antibiotic resistance.
Area of Science:
- Microbiology
- Cell Biology
- Biotechnology
Background:
- Extracellular vesicles (Evs) mediate intercellular communication, transporting proteins, nucleic acids, and lipids.
- Antibiotic resistance, particularly from *Pseudomonas aeruginosa*, poses a significant global health threat.
- Evs are being explored for biotechnological applications.
Purpose of the Study:
- To review advances in understanding the role of Evs in *Pseudomonas aeruginosa* pathogenicity over the last decade.
- To examine the potential of Evs in developing novel treatment strategies against antibiotic-resistant bacteria.
Main Methods:
- Literature review of studies on *Pseudomonas aeruginosa* Evs.
- Analysis of Evs' molecular cargo and their impact on host-pathogen interactions.
- Evaluation of Evs' therapeutic potential in preclinical and clinical contexts.
Main Results:
- Evs contribute to *Pseudomonas aeruginosa*'s virulence by delivering effector molecules.
- Evs are involved in biofilm formation and host immune modulation.
- Recent research highlights specific Evs components with potential as therapeutic targets.
Conclusions:
- Evs are critical mediators of *Pseudomonas aeruginosa* pathogenicity.
- Targeting Evs or their cargo presents a promising avenue for combating antibiotic resistance.
- Further research into Evs biology and function is crucial for therapeutic development.
Related Concept Videos
01:18Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
01:28Gene Regulation in Microbial Communities: Quorum Sensing
01:18Outer Layers of the Cell Envelope
01:36Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
01:31Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
01:10Intracellular Movement of Viruses and Bacteria